Page last updated: 2024-08-21

erythromycin and Granulocytic Leukemia, Chronic

erythromycin has been researched along with Granulocytic Leukemia, Chronic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barni, R; Brueggen, J; Cabrita, G; Cleris, L; Corneo, G; Cozens, R; D'Incalci, M; Formelli, F; Gambacorti-Passerini, C; Gianazza, E; le Coutre, P; Pioltelli, P; Pogliani, E; Rossi, F; Zucchetti, M	1

Other Studies

1 other study(ies) available for erythromycin and Granulocytic Leukemia, Chronic

Article	Year
Role of alpha1 acid glycoprotein in the in vivo resistance of human BCR-ABL(+) leukemic cells to the abl inhibitor STI571. Journal of the National Cancer Institute, 2000, Oct-18, Volume: 92, Issue:20 Topics: Animals; Antineoplastic Agents; Benzamides; Blotting, Western; Drug Resistance, Neoplasm; Drug Synergism; Drug Therapy, Combination; Enzyme Inhibitors; Erythromycin; Female; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Mice, Nude; Orosomucoid; Phosphorylation; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Time Factors; Tumor Cells, Cultured	2000

Article

Year

Role of alpha1 acid glycoprotein in the in vivo resistance of human BCR-ABL(+) leukemic cells to the abl inhibitor STI571.

Journal of the National Cancer Institute, 2000, Oct-18, Volume: 92, Issue:20

Topics: Animals; Antineoplastic Agents; Benzamides; Blotting, Western; Drug Resistance, Neoplasm; Drug Synergism; Drug Therapy, Combination; Enzyme Inhibitors; Erythromycin; Female; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Mice, Nude; Orosomucoid; Phosphorylation; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Time Factors; Tumor Cells, Cultured

2000